Doctors call new ALS drug a "game changer" | WPBN
October 20, 2017 - als
GRAND TRAVERSE COUNTY, Mi. (WPBN/WGTU) —
There’s a new drug to assistance ALS patients and doctors are job it a diversion changer.
It’s called Radicava.
It was only authorized by a FDA in May and is a initial drug authorized for ALS in some-more than 22 years.
ALS is a fast on-going neurodegenerative illness where a infancy of patients die within dual to 5 years of diagnosis.
Radicava has been shown to delayed a decrease of earthy duty in ALS patients by 33 percent.
Munson Medical Center only got authorized to discharge a drug to patients in Traverse City during a Cowell Family Cancer Center.
“For decades we’ve had one remedy that’s unequivocally causing a statistical benefit,” pronounced Dr. Cornelius Robens, M.D., a neurologist. “This remedy seems to be a initial that is unequivocally causing a change. It’s a diversion changer. This is kind of a final illness that we can consider of where we have not had a lot to offer and now that’s changing.”
Munson does not have a timeline for when Radicava will be accessible there, though doctors contend it will be soon.